My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Fri 27 Nov 2009 | 2:55 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Anika Therapeutics Inc
Anika Therapeutics Inc (ANIK.O) (Nasdaq)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
ANIK
on other exchanges
As of 25 Nov 2009
8.03
USD
Price Change
-0.09
Percent Change
-1.11%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Dec 2008
Bower, Joseph
--
--
--
--
Carter, Andrew
292,800
--
160,165
492,012
Davidson, Eugene
--
--
--
--
Kulinets, Irina
299,000
--
28,394
348,098
Land, Raymond
--
--
--
--
Luppino, Frank
190,298
--
83,697
273,995
Moran, John
--
--
--
--
Mrachek, William
261,965
--
72,057
373,055
Quinlan, Kevin
324,471
--
174,936
537,872
Sherwood, Charles
621,296
--
310,803
1,039,214
Wheeler, Steven
--
--
--
--
Wilhoite, Randall
179,349
--
38,423
217,772
Find out more about ANIK.O
Insider Trading